Search for: "MEDICARE" Results 41 - 60 of 28,516
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 May 2024, 12:47 pm by John Ross
The Public Health Service Act requires pharmaceutical manufacturers who participate in Medicare or Medicaid to sell certain drugs at discounted prices to select healthcare providers, like hospitals serving low-income patients. [read post]
24 May 2024, 9:46 am by Sadie Mayhew
    Rapha Healthcare:  On Tuesday (May 21), DOJ announced a consent judgment ordering Sharon Raynes Halliday and her practice, Rapha Healthcare Services, to pay $500,000 to settle False Claims Act and Controlled Substances Act charges of billing Medicare/Medicaid for unauthorized and invalid prescriptions for controlled substances. [read post]
24 May 2024, 7:27 am by davidowlaw.com
May 23, 2024 • Volume 5 Issue 246 INTERESTING NEW LAW A federal mandate that sets minimum staffing requirements for nursing homes was recently finalized by the Centers for Medicare and Medicaid Services (CMS). [read post]
24 May 2024, 7:22 am by Stefana
Self-employment taxes currently total 15.3%: 12.4% of that goes toward Social Security, while the remaining 2.9% goes toward Medicare. [read post]
24 May 2024, 6:00 am by David Lillesand
  Approximately 49% of Medicare beneficiaries elect Medicare Advantage plans. [read post]
23 May 2024, 10:00 pm
At a time when pharmaceutical drug prices are at the height of political scrutiny, manufacturers can breathe a small sigh of relief as the Centers for Medicare and Medicaid Services (CMS) announced on May 15, 2024 that it will not, at this time, finalize its best price stacking provision in its May 23, 2023 Medicaid Drug Rebate Program (MDRP) proposed rule . [read post]
23 May 2024, 10:00 pm
At a time when pharmaceutical drug prices are at the height of political scrutiny, manufacturers can breathe a small sigh of relief as the Centers for Medicare and Medicaid Services (CMS) announced on May 15, 2024 that it will not, at this time, finalize its best price stacking provision in its May 23, 2023 Medicaid Drug Rebate Program (MDRP) proposed rule . [read post]
23 May 2024, 10:00 pm
At a time when pharmaceutical drug prices are at the height of political scrutiny, manufacturers can breathe a small sigh of relief as the Centers for Medicare and Medicaid Services (CMS) announced on May 15, 2024 that it will not, at this time, finalize its best price stacking provision in its May 23, 2023 Medicaid Drug Rebate Program (MDRP) proposed rule . [read post]
23 May 2024, 10:00 pm
At a time when pharmaceutical drug prices are at the height of political scrutiny, manufacturers can breathe a small sigh of relief as the Centers for Medicare and Medicaid Services (CMS) announced on May 15, 2024 that it will not, at this time, finalize its best price stacking provision in its May 23, 2023 Medicaid Drug Rebate Program (MDRP) proposed rule . [read post]
23 May 2024, 10:00 pm
At a time when pharmaceutical drug prices are at the height of political scrutiny, manufacturers can breathe a small sigh of relief as the Centers for Medicare and Medicaid Services (CMS) announced on May 15, 2024 that it will not, at this time, finalize its best price stacking provision in its May 23, 2023 Medicaid Drug Rebate Program (MDRP) proposed rule . [read post]
23 May 2024, 10:00 pm
At a time when pharmaceutical drug prices are at the height of political scrutiny, manufacturers can breathe a small sigh of relief as the Centers for Medicare and Medicaid Services (CMS) announced on May 15, 2024 that it will not, at this time, finalize its best price stacking provision in its May 23, 2023 Medicaid Drug Rebate Program (MDRP) proposed rule . [read post]
23 May 2024, 9:05 pm by Samantha Heavner
The Centers for Medicare & Medicaid Services proposed a rule that would establish a new mandatory Medicare payment model to test the impact of performance-based incentive payments on the kidney transplant system. [read post]
Further, a new group of organizations with varied experience interfacing with FDA will need to navigate the intricacies of being a regulated entity under the FDCA and understanding what it means to be subject to ongoing FDA oversight, in addition to ongoing interactions with the Centers for Medicare & Medicaid Services (CMS). [read post]
20 May 2024, 10:00 pm by Sherica Celine
HHS is also revising its interpretation regarding whether Medicare Part B constitutes federal financial assistance for purposes of civil rights enforcement. 89 Fed. [read post]
20 May 2024, 12:14 pm by Yosi Yahoudai
Ophelia partnered with Highmark Wholecare last March to provide telehealth addiction services to its patients, which includes Pennsylvania-based Medicaid and Medicare members; in April, it was designated as Pennsylvania’s first virtual Center of Excellence for opioid use disorder. [read post]
20 May 2024, 7:35 am by Robert N. Katz, Esq.
Medicare warnings to nursing homes that are believed to engage in the overuse of antipsychotic drugs among their residents can help reduce these dangerous practices. [read post]
20 May 2024, 12:31 am by Sara E. Teller
Those on government-funded plans are still having a hard time getting access to treatment. [read post]
19 May 2024, 9:05 pm by The Regulatory Review
Sep 21, 2023 | HHS Selects Drugs for Medicare Price Negotiation | Biden Administration introduces price regulation to the pharmaceutical industry. [read post]